Picture of Corestemchemon logo

166480 Corestemchemon Income Statement

0.000.00%
kr flag iconLast trade - 00:00
HealthcareSpeculativeSmall CapMomentum Trap

Annual income statement for Corestemchemon, fiscal year end - December 31st, KRW millions except per share, conversion factor applied.

2019
December 31st
2020
December 31st
2021
December 31st
R2022
December 31st
2023
December 31st
Period Length:12 M12 M12 M12 M12 M
Source:Annual Audited AccountsAnnual Audited AccountsAnnual Audited AccountsAnnual Audited AccountsAnnual Audited Accounts
Standards:
IFRS
IFRS
IFRS
IFRS
IFRS
Status:FinalFinalFinalFinalFinal
Revenue
Total Revenue24,28426,35830,24045,87833,657
Cost of Revenue
Gross Profit4,9394,9507,98615,2443,493
Selling / General / Administrative Expenses
Research And Development
Depreciation and Amortization
Unusual Expense / Income
Other Operating Expenses
Total Operating Expenses29,37333,36840,79053,84855,229
Operating Profit-5,088-7,011-10,550-7,970-21,572
Gain / Loss on Sale of Assets
Total Net Non Operating Interest Income / Expense
Other Net Non Operating Costs
Net Income Before Taxes-3,481-18,011-4,4253,407-17,676
Provision for Income Taxes
Net Income After Taxes-4,370-22,384-4,996702-17,672
Minority Interest
Net Income Before Extraordinary Items
Net Income-5,168-23,187-6,999-2,257-17,672
Income Available to Common Shareholders Excluding Extraordinary Items
Income Available to Common Shareholders Including Extraordinary Items
Dilution Adjustment
Diluted Net Income-5,168-23,187-6,999-2,257-17,672
Diluted Weighted Average Shares
Basic EPS Including Extraordinary Items
Diluted EPS Including Extraordinary Items
Diluted EPS Excluding Extraordinary Items
Normalised Income Before Taxes
Normalised Income After Taxes
Normalised Income Available to Common Shareholders
Diluted Normalised EPS-329-1,475-444-74.5-760
Dividends per Share